Tri­ci­da 'fore­shad­owed' its CRL — but shares still fall with fear of years-long de­lay

No­body likes re­jec­tions. But it does help to have a heads-up.

Such is the case at Tri­ci­da, which was slapped with a

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.